Syrups for hoarseness of voice in a child

One of the forms of release of medicinal preparations, used for treatment of children from birth – is syrups. In case of hoarseness of voice in a child, which is caused by laryngitis, cough or other colds, two types of syrups are used:

• Medicines that facilitate the expectoration of sputum.
• Cough suppressants.

Syrups for children, unlike drugs for adults, have a milder composition and, when used correctly, do not have a negative systemic effect on the body.

Let's look at the most effective drugs for children:

Ambrobene

Mucolytic, stimulates prenatal lung development. Has secretolytic, expectorant and secretomotor properties. Ambrobene stimulates serous cells of the bronchial mucosa glands, normalizes the ratio of serous and mucous components of sputum. Reduces sputum viscosity and accelerates its removal.

• Indications for use: respiratory diseases with viscous sputum. Bronchitis (acute, chronic), pneumonia, bronchial asthma, chronic obstructive pulmonary disease. Stimulation of prenatal lung development, respiratory distress syndrome in newborns and premature babies.
• Method of administration: for children under two years old, 2.5 ml 2 times a day, for children from 2 to 5 years old, 2.5 ml 3 times a day, for patients from 5 to 12 years old, 5 ml 2-3 times a day. If a solution is used, it is used 1 ml 2 times a day for children under 2 years old, 1 ml 3 times a day from 2 to 5 years old and 2 ml for patients 5-12 years old.
• Side effects: allergic reactions, headaches, weakness, dry mouth and respiratory tract, diarrhea, rhinorrhea, dysuria. With prolonged use, there is a risk of nausea and vomiting. Cases of overdose have not been recorded.
• Contraindications: hypersensitivity reactions, gastric ulcer and duodenal ulcer, first trimester of pregnancy, lactation.

Release form: syrup 15 mg/5 ml 100 ml, bottle; solution for oral administration 7.5 mg/ml 100 ml, bottle; retard capsules, tablets, injection solution.

Ambroxol

Bromhexine derivative. Stimulates organs responsible for mucus production in the larynx, creating a good expectorant effect. Ambroxol has mucolytic properties (liquefies sputum). Stimulates surfactant formation, normalizes altered bronchopulmonary secretion and improves rheological parameters of sputum (reduces viscosity and adhesive properties).

• Indications for use: acute and chronic inflammatory diseases of the bronchi, lungs, trachea. Pneumoconiosis, bronchiectasis, preparation for bronchography. The drug can be used to stimulate the formation of surfactant in premature babies and newborns with respiratory failure syndrome.
• Method of application: the dosage and duration of use of the syrup are selected by the attending physician, individually for each patient.
• Side effects: attacks of nausea and vomiting, hypersensitivity reactions. Overdose has similar signs, treatment is symptomatic.

Release form: syrup 15 mg/15 ml in 100 ml bottles, solution for inhalation, tablets, ampoules.

Omnitus

A medicinal product based on butamirate citrate. It has bronchodilatory and anti-inflammatory properties. It suppresses cough reflexes by acting on the corresponding areas of the brain.

• Indications for use: whooping cough, bronchitis, acute respiratory viral infections, flu and other diseases with dry cough. The medicine is prescribed to eliminate coughing fits before and after surgical interventions, during operations on the organs of the chest cavity, bronchoscopy.
• Method of administration: for children from 3 to 6 years old, 10 ml of syrup 3 times a day, for patients from 6 to 9 years old, 15 ml 3 times a day, for children over 9 years old, 3 measuring spoons of the medicine 3-4 times a day. The duration of therapy is determined by the attending physician.
• Side effects: headaches, dizziness, nausea and vomiting, allergic reactions, skin rashes.
• Contraindications: hypersensitivity to the components of the drug, patients under 3 years of age.
• Overdose: hypotension, dizziness, vomiting, diarrhea. Treatment is symptomatic with the use of adsorbents and laxatives.

Release form: syrup in 200 ml bottles with a 50 ml measuring spoon. Tablets of 20 and 50 mg in blisters of 10 pieces.

Sinekod

Antitussive non-narcotic drug of direct action with the active component - butamirate. The active substance Sinekod blocks the cough center in the medulla oblongata and does not depress the respiratory center. The drug also has bronchodilator and anti-inflammatory properties, improves blood oxygen supply and spirometry indicators.

• Indications for use: unproductive cough of various etiologies, dry cough in whooping cough and respiratory diseases. Suppression of the cough reflex for diagnostic and surgical interventions.
• Directions for use: before meals, dissolving the syrup in a small amount of water. For children aged 3-6 years, 5 ml of syrup is prescribed 3 times a day, for children aged 6-12 years, 10 ml of the medicine 3 times a day, for patients over 12 years, 15 ml 3 times a day. If oral drops are used, then for children aged 2 months to a year, 10 drops are prescribed 3-4 times a day, for children over a year, 15-25 drops 4 times a day. The dosage and duration of therapy are determined by the attending physician, individually for each patient.
• Side effects: headaches, increased fatigue, dizziness, nausea, vomiting, bowel disorders, various allergic reactions.
• Contraindications: hypersensitivity to the components of the drug, pulmonary hemorrhage, first trimester of pregnancy. The syrup is not prescribed to children under 3 years old, and oral drops for babies up to 2 months.
• Overdose: nausea, vomiting, decreased blood pressure, loss of consciousness, dizziness. Treatment includes gastric lavage, intake of enterosorbents with further symptomatic therapy.

Release form: syrup in 200 ml bottles, drops for oral use in 20 ml bottles.

Codelac Neo

Antitussive drug of central action. Contains the active component butamirate citrate from the group of non-opioid substances. Has antitussive, anti-inflammatory and expectorant properties. Bronchodilating activity is manifested.

Indications for use: symptomatic therapy of unproductive cough in various respiratory diseases, whooping cough. Dry cough before/after surgical or diagnostic manipulations.

• Method of administration: orally before meals, the dosage and duration of therapy is determined by the attending physician. For children from 3 to 6 years old, 5 ml of syrup is prescribed 3 times a day, for patients from 6 to 12 years old, 10 ml of the drug 2-3 times a day. The average duration of treatment is 3-5 days.
• Side effects: headaches and dizziness, bowel disorders, nausea, pain in the epigastric region, various allergic reactions.
• Contraindications: individual intolerance to the components of the drug, syrup is contraindicated for patients under 3 years of age, and drops for children under 2 months of age.
• Overdose: dizziness, decreased blood pressure, nausea and vomiting, increased drowsiness and fatigue. There is no specific antidote, treatment is symptomatic. Gastric lavage, intake of enterosorbent and laxative drugs are indicated.

Release form: syrup of 100 and 200 ml in glass bottles, drops for oral administration of 20 ml in dark glass bottles.

The choice of medicine is made by the attending physician. The doctor is guided by the severity of the painful symptoms and the characteristics of the patient's body.